Edwards Lifesciences CVP Daniel Lippis sells $54,168 in stock
Covered in this story
What has happened since
- Edwards Lifesciences is up 4.3% since this was published, 38 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Edwards Lifesciences
- TD Cowen: $84.5 → $104 by Jul 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $EW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Edwards Lifesciences →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.